Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Abbreviated New Drug...

    Tag: abbreviated new drug application

    You Searched For "Abbreviated New Drug Application"
    Indoco Remedies gets USFDA ANDA nod for Glycopyrrolate Injection

    Indoco Remedies gets USFDA ANDA nod for Glycopyrrolate Injection

    Medical Dialogues Bureau3 Nov 2019 10:00 AM IST
    Glycopyrrolate is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the...
    Mylan launches generic version of Faslodex Injection to treat breast cancer

    Mylan launches generic version of Faslodex Injection to treat breast cancer

    Medical Dialogues Bureau19 Sept 2019 9:35 AM IST
    New Delhi: Mylan N.V. recently announced the U.S. launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, a generic...
    Granules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tablets

    Granules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tablets

    Medical Dialogues Bureau7 Aug 2019 9:30 AM IST
    Amphetamine Sulfate tablets is a generic version of Arbor Pharmaceuticals LLC's Evekeo tablets in similar strength, it added.New Delhi: Drug firm...
    Swiss company Actelion moves US court against Natco Pharma over generic of its patented drug

    Swiss company Actelion moves US court against Natco Pharma over generic of its patented drug

    Medical Dialogues Bureau5 Jun 2019 12:27 PM IST
    Hyderabad: Swiss pharma company Actelion Pharmaceuticals Ltd has filed a petition in a US court alleging that Natco Pharma and its US partner Syneos...
    Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

    Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

    Farhat Nasim28 May 2019 10:00 AM IST
    The approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
    Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets

    Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets

    Farhat Nasim8 May 2019 10:15 AM IST
    Nitroglycerin sublingual tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood...
    Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer

    Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer

    Farhat Nasim27 Feb 2019 9:30 AM IST
    The company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection...
    Alembic Pharma gets USFDA nod for Acetazolamide extended release capsules

    Alembic Pharma gets USFDA nod for Acetazolamide extended release capsules

    Farhat Nasim21 Feb 2019 9:45 AM IST
    Acetazolamide extended-release capsule is therapeutically equivalent to the reference listed drug, Diamox Sequels, 500 mg, of Teva Branded...
    Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

    Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

    Farhat Nasim17 Feb 2019 9:30 AM IST
    The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Olopatadine...
    Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

    Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

    Medical Dialogues Bureau10 Dec 2018 9:15 AM IST
    New Delhi: Drug firm Alembic Pharma on Monday said it has received approval from the US health regulator for Olopatadine Hydrochloride ophthalmic...
    Granules gets 2 observation by USFDA for U.S Unit

    Granules gets 2 observation by USFDA for U.S Unit

    Medical Dialogues Bureau30 Oct 2018 10:48 AM IST
    New Delhi: Pharma firm Granules through a recent regulatory filing announced its US subsidiary has received two observations from the US health...
    Mylan launches generic Angiomax injection

    Mylan launches generic Angiomax injection

    Ruby Khatun Khatun22 Jun 2018 10:15 AM IST
    HERTFORDSHIRE, England, and PITTSBURGH: Global pharmaceutical company Mylan N.V. announced the U.S. launch of Bivalirudin for Injection, 250 mg...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok